The Mechanism of Extracellular Vesicles Containing Mitochondrial DNA in ARDS Lung Injury Caused by Extrapulmonary Sepsis
1 other identifier
observational
50
0 countries
N/A
Brief Summary
The acute respiratory distress syndrome (ARDS) remains a common and morbid complication of critical illness. Sepsis contribute to a lot of ARDS cases, but mechanisms by which non-pulmonary insults such as extrapulmonary sepsis propagate lung injury remain unclear. Most eukaryotic cells release small anuclear membrane-bound vesicles into the extracellular environment in either physiological or pathophysiological conditions, often called extracellular vesicles (EVs) .Through their cargo containing bioactive molecules such as proteins, mRNAs, and microRNAs and their interaction with target cells, EVs are recognized as important mediators of cellular communication. Mitochondrial contents are clearly present in EVs, and mitochondrial cargo within EVs have been shown to stimulate the production of proinflammatory cytokines, further enhancing LPS-induced inflammation. Among the mitochondrial contents, mtDNA was present at higher levels in EVs.Therefore, we hypothesis, EVs containing mtDNA play an important role in the occurrence and development of ARDS caused by extrapulmonary sepsis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2021
CompletedFirst Posted
Study publicly available on registry
September 29, 2021
CompletedStudy Start
First participant enrolled
October 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedSeptember 29, 2021
September 1, 2021
11 months
September 18, 2021
September 18, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
28-day mortality
All patients were followed up for 28 days
Secondary Outcomes (2)
Ventilator days
All patients were followed up for 28 days
ICU stay
All patients were followed up for 28 days
Eligibility Criteria
We enrolled patients with ARDS caused by abdominal infection
You may qualify if:
- Patients with ARDS caused by abdominal infection
You may not qualify if:
- age \<18 years old or pregnancy; death or discharge within 24 hours after admission; advanced tumor
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University
Study Record Dates
First Submitted
September 18, 2021
First Posted
September 29, 2021
Study Start
October 1, 2021
Primary Completion
September 1, 2022
Study Completion
December 31, 2022
Last Updated
September 29, 2021
Record last verified: 2021-09